| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3476(99)70169-1 |
| P698 | PubMed publication ID | 10518080 |
| P2093 | author name string | Shinohara M | |
| Morikawa A | |||
| Sone K | |||
| Tomomasa T | |||
| P2860 | cites work | Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases | Q34190260 |
| Diagnosis and therapy of Kawasaki disease in children | Q34364775 | ||
| Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose | Q34452119 | ||
| A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome | Q34580488 | ||
| Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study | Q42263814 | ||
| Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids | Q42557663 | ||
| Treatment of Kawasaki disease with corticosteroid. | Q54490906 | ||
| Intravenous γ-Globulin Treatment in Kawasaki Disease | Q56454078 | ||
| The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin | Q58478448 | ||
| A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease | Q70486901 | ||
| Morphologic and functional assessment of coronary aneurysm after Kawasaki disease by repeated dipyridamole-loading coronary angiography | Q77108414 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 465-469 | |
| P577 | publication date | 1999-10-01 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Corticosteroids in the treatment of the acute phase of Kawasaki disease | |
| P478 | volume | 135 |
| Q35772471 | A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease |
| Q28165245 | An update on Kawasaki disease |
| Q39654279 | Cardiovascular involvement in Kawaski Disease |
| Q33941598 | Clinical outcomes of initial dexamethasone treatment combined with a single high dose of intravenous immunoglobulin for primary treatment of Kawasaki disease |
| Q34309769 | Combination therapy in autoimmune disease: vasculitis |
| Q37585123 | Corticosteroid therapy for primary treatment of Kawasaki disease - weight of evidence: a meta-analysis and systematic review of the literature |
| Q40549286 | Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children |
| Q40100533 | Efficacy of glucocorticoids combined with immunoglobulin in initial treatment of Kawasaki disease: a Meta analysis |
| Q50958607 | Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. |
| Q28167239 | Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease |
| Q84964796 | External Validation of a Risk Score to Predict Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease |
| Q54144614 | Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version). |
| Q28222748 | Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab |
| Q40579573 | Kawasaki Disease: Current Therapeutic Perspectives |
| Q24654153 | Kawasaki disease |
| Q28222919 | Kawasaki disease |
| Q37289341 | Kawasaki disease at British Columbia's Children's Hospital. |
| Q34093837 | Kawasaki disease with predominant central nervous system involvement |
| Q28219279 | Kawasaki disease: 40 years after the original report |
| Q28192172 | Kawasaki disease: an update |
| Q40402609 | Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease |
| Q58921960 | Management of Kawasaki disease: corticosteroids revisited |
| Q24604335 | Medium-size-vessel vasculitis |
| Q35617543 | Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease |
| Q28191172 | Pharmacological therapy for patients with Kawasaki disease |
| Q35684461 | Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature |
| Q33652518 | Pustulovesicular Skin Eruption as Presenting Feature of Incomplete Kawasaki Disease |
| Q28184382 | Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy |
| Q40593999 | Recognizing Kawasaki disease |
| Q82102679 | Regulation of oxidative stress in patients with Kawasaki disease |
| Q50144746 | Role of glucocorticoids in Kawasaki disease |
| Q46555559 | Standard-dose and short-term corticosteroid therapy in immunoglobulin-resistant Kawasaki disease |
| Q24194442 | Steroid hormone treatment for Kawasaki disease in children |
| Q24242875 | Steroid hormone treatment for Kawasaki disease in children |
| Q51391893 | Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease. |
| Q36600699 | The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases |
| Q39653469 | The use of anticoagulation in pediatric cardiac disease. |
| Q44746938 | The use of corticosteroid therapy in refractory Kawasaki patients |
| Q73075286 | Treatment of Kawasaki disease: corticosteroids revisited |
| Q28194172 | Update on the treatment of Kawasaki disease in childhood |
| Q26777190 | Use of corticosteroids during acute phase of Kawasaki disease |
| Q35680229 | Vascular and connective tissue diseases in the paediatric world |
| Q81532252 | [Corticoid use in the treatment of Kawasaki disease] |
Search more.